Zenith Alpha G35369Recalls & reported problems
William Cook Europe ApS · Zenith Alpha, Thoracic Endovascular Graft, Proximal Component · Class 3 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10827002353692), received between May 3, 2018 and Dec 16, 2022 — classified as 3 injuries.
The most frequently reported specific device problem is “Device Tipped Over” (2 reports).
2 other recalls cover devices cleared under the same FDA submission (P140016); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Device Tipped Over2
- Activation, Positioning or Separation Problem1
- Kinked1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- No Code Available1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryDec 16, 2022Device Tipped Over; Device Tipped Over
DESCRIPTION OF EVENT ACCORDING TO INITIAL REPORTER: UPON DEPLOYMENT OF THE DEVICE, THE PROXIMAL EDGE OF THE GRAFT WAS TIPPED SIDEWAYS. THEY SUCCESSFULLY COMPLETED THE PROCEDURE BY REMOVING THE DELIVERY SYSTEM AND BALLOONING THE PROXIMAL EDGE OF THE GRAFT TO GET IT TO OPPOSE THE AORTIC WALL. PATIENT OUTCOME: THE PATIENT DID NOT REQUIRE ANY ADDITIONAL PROCEDURES DUE TO THIS OCCURRENCE. ACCORDING TO THE INITIAL REPORTER, THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS DUE TO THIS OCCURRENCE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15996529 ↗InjuryDec 7, 2022Device Tipped Over; Device Tipped Over
DESCRIPTION OF EVENT ACCORDING TO INITIAL REPORTER: UPON DEPLOYMENT OF THE DEVICE, THE PROXIMAL EDGE OF THE GRAFT WAS TIPPED SIDEWAYS. THEY SUCCESSFULLY COMPLETED THE PROCEDURE BY REMOVING THE DELIVERY SYSTEM AND BALLOONING THE PROXIMAL EDGE OF THE GRAFT TO GET IT TO OPPOSE THE AORTIC WALL. PATIENT OUTCOME: THE PATIENT DID NOT REQUIRE ANY ADDITIONAL PROCEDURES DUE TO THIS OCCURRENCE. ACCORDING TO THE INITIAL REPORTER, THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS DUE TO THIS OCCURRENCE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15930105 ↗InjuryMay 3, 2018Kinked; Activation, Positioning or Separation Problem; Kinked; Activation, Positioning or Separation Problem
DESCRIPTION OF EVENT ACCORDING TO INITIAL REPORTER: "THE DEVICE, UPON DEPLOYMENT (SPECIFICALLY DEPLOYMENT OF THE TRIGGER WIRES) ENFOLDED ON ITSELF. DEVICE WAS IN THE PATIENT ALREADY, AND ENFOLDED IN A WAY THAT ANOTHER PIECE WAS ADDED AND WHICH EXTENDED BOTH PROXIMALLY AND DISTALLY FROM THE ORIGINAL DEVICE; THIS BYPASSED THE ENFOLDING ISSUE. PHYSICIAN DETERMINED IT WOULD BE TOO DANGEROUS TO TRY TO STRAIGHTEN BY THE BALLOON". PATIENT OUTCOME: THE FAILING DEVICE DID MAKE THE AORTA SMALLER.
Patient problems: No Code Available
MAUDE report 7482247 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P140016. One submission often covers many models, so check the product and lot details in each record.
- Z-0043-2026 · Sep 18, 2025 · Open, ClassifiedZenith Alpha 2 Thoracic Endovascular Graft, Catalog Prefix ZTA2- Reference Part Numbers ZTA2-P-40-117-W ZTA2-P-40-167 ZTA2-P-40-167-W ZTA2-P-40-217-W ZTA2-P-42-121 ZTA2-P-42-121-W
- Z-2099-2017 · Mar 22, 2017 · TerminatedZenith Alpha Thoracic Endovascular Graft The Zenith Alpha" Thoracic Endovascular Graft is indicated for the endovascular treatment of patients with isolated lesions of the descend
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page